Yamyamin, Chesil .
HRN: 23-54-28 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
CEFTAZIDIME 1GM (VIAL)
08/17/2023
08/24/2023
IV
2g
Q8H
Speticemia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes